...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Annual Financial Reporting
4
Mar 22, 2024 12:55PM
1
Mar 22, 2024 03:10PM
2
Mar 22, 2024 03:46PM

"Anxious to know HL's intention. Renew or convert. Tic Toc!"

we need a lot more than hepa to renew. Can't see either happening with their guy stepping down. Still say, Zenith deal that flows money into rvx would be the best for both companies ,their shareholder's & futures. In fact it's the only thing that works imo , hepa converting at this level , disaster.

glta 

1
Mar 22, 2024 04:57PM
1
Mar 22, 2024 05:43PM
2
Mar 23, 2024 10:17AM
1
Mar 23, 2024 06:16PM
1
Mar 23, 2024 07:48PM
3
Mar 23, 2024 08:04PM
1
Mar 23, 2024 08:21PM
Share
New Message
Please login to post a reply